Bayer | BAYN - Assets



Bayer reported EUR105.24B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Air Liquide EUR 49.34B 2.53B Jun/2025
Akzo Nobel EUR 14.17B 680M Jun/2025
Alcon AG USD 31.39B 379M Jun/2025
Amarin USD 655.68M 29.67M Mar/2025
Arkema EUR 13.92B 386M Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
BASF EUR 77.67B 3.75B Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Beiersdorf EUR 12.92B 87M Jun/2025
Corteva USD 41.76B 364M Jun/2025
Covestro EUR 13.21B 844M Jun/2025
Essilor EUR 61.93B 2.34B Jun/2025
Fresenius EUR 41.32B 1.89B Jun/2025
Fresenius Medical Care EUR 31.29B 1.44B Jun/2025
Genmab DKK 6.46B 122M Jun/2025
Givaudan CHF 12.18B 1.05B Jun/2024
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
GRIFOLS EUR 19.77B 1.21B Jun/2025
Henkel EUR 32.79B 2.48B Jun/2025
Hikma Pharmaceutical USD 5.13B 286M Dec/2024
Johnson Matthey GBP 6.19B 59M Mar/2025
Linde USD 86.08B 5.93B Jun/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 47.35B 2.02B Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Nutrien USD 53.26B 186M Jun/2025
Philips EUR 26.38B 788M Jun/2025
PPG Industries USD 22.1B 959M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sanofi 124.96B 6.93B Jun/2025
SAP EUR 68.4B 7.23B Jun/2025
Solvay EUR 6.3B 48M Jun/2025
UCB EUR 17.35B 1.72B Dec/2024
Umicore EUR 8.59B 817.3M Jun/2025
Vinci EUR 130.45B 954M Jun/2025